522 related articles for article (PubMed ID: 9927406)
1. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the acute effects of a selective endothelin ETA and a mixed ETA/ETB receptor antagonist in heart failure.
Ohnishi M; Wada A; Tsutamoto T; Fukai D; Kinoshita M
Cardiovasc Res; 1998 Sep; 39(3):617-24. PubMed ID: 9861304
[TBL] [Abstract][Full Text] [Related]
3. Chronic effects of an endothelin-converting enzyme inhibitor on cardiorenal and hormonal function in heart failure.
Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Yamamoto T; Wang X; Kinoshita M
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():254S-257S. PubMed ID: 12193098
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of selective endothelin ETA and ETB receptor antagonists in congestive heart failure.
Wada A; Tsutamoto T; Fukai D; Ohnishi M; Maeda K; Hisanaga T; Maeda Y; Matsuda Y; Kinoshita M
J Am Coll Cardiol; 1997 Nov; 30(5):1385-92. PubMed ID: 9350944
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 promotes vascular structural remodeling during the progression of heart failure prevention of vascular remodeling using a specific endothelin-converting enzyme inhibitor.
Wang X; Ohnishi M; Wada A; Tsutamoto T; Sawaki M; Fujii M; Matsumoto T; Yamamoto T; Kurokawa K; Yamada H; Kinoshita M
Life Sci; 2001 Oct; 69(21):2477-88. PubMed ID: 11693256
[TBL] [Abstract][Full Text] [Related]
6. Chronic oral endothelin type A receptor antagonism in experimental heart failure.
Borgeson DD; Grantham JA; Williamson EE; Luchner A; Redfield MM; Opgenorth TJ; Burnett JC
Hypertension; 1998 Mar; 31(3):766-70. PubMed ID: 9495259
[TBL] [Abstract][Full Text] [Related]
7. Effect of a highly selective endothelin-converting enzyme inhibitor on cardiac remodeling in rats after myocardial infarction.
Martin P; Tzanidis A; Stein-Oakley A; Krum H
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S367-70. PubMed ID: 11078422
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).
Lüscher TF; Enseleit F; Pacher R; Mitrovic V; Schulze MR; Willenbrock R; Dietz R; Rousson V; Hürlimann D; Philipp S; Notter T; Noll G; Ruschitzka F;
Circulation; 2002 Nov; 106(21):2666-72. PubMed ID: 12438291
[TBL] [Abstract][Full Text] [Related]
9. Effects of endothelin receptor A antagonist FR139317 on rats with congestive heart failure.
Chen XC; Zhang XM; Luo NS; Fang C; Liu YM; Wu W
Acta Pharmacol Sin; 2001 Oct; 22(10):896-900. PubMed ID: 11749771
[TBL] [Abstract][Full Text] [Related]
10. Endothelin A receptor antagonism in experimental congestive heart failure results in augmentation of the renin-angiotensin system and sustained sodium retention.
Schirger JA; Chen HH; Jougasaki M; Lisy O; Boerrigter G; Cataliotti A; Burnett JC
Circulation; 2004 Jan; 109(2):249-54. PubMed ID: 14691038
[TBL] [Abstract][Full Text] [Related]
11. Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors.
Love MP; Haynes WG; Gray GA; Webb DJ; McMurray JJ
Circulation; 1996 Nov; 94(9):2131-7. PubMed ID: 8901663
[TBL] [Abstract][Full Text] [Related]
12. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
Wada A; Tsutamoto T; Matsuda Y; Kinoshita M
Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118
[TBL] [Abstract][Full Text] [Related]
13. Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure.
Ohnishi M; Wada A; Tsutamoto T; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Wang X; Kinoshita M
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():241S-244S. PubMed ID: 12193095
[TBL] [Abstract][Full Text] [Related]
14. Chronic effects of a novel, orally active endothelin receptor antagonist, T-0201, in dogs with congestive heart failure.
Ohnishi M; Wada A; Tsutamoto T; Fukai D; Sawaki M; Maeda Y; Kinoshita M
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S236-8. PubMed ID: 9595447
[TBL] [Abstract][Full Text] [Related]
15. Endothelin mediates the altered renal hemodynamics associated with experimental congestive heart failure.
Qiu C; Ding SS; Hess P; Clozel JP; Clozel M
J Cardiovasc Pharmacol; 2001 Aug; 38(2):317-24. PubMed ID: 11483881
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiological roles of endogenous endothelin-1 in dogs with chronic heart failure produced by rapid right ventricular pacing.
Tadano K; Suzuki J; Hanada K; Nakao M; Nakao R; Uehara S; Ohta H; Miyauchi T; Nishikibe M
J Pharmacol Exp Ther; 2001 Aug; 298(2):729-36. PubMed ID: 11454937
[TBL] [Abstract][Full Text] [Related]
17. Significant roles of endothelin-A- and -B-receptors in renal function in congestive heart failure.
Ohnishi M; Wada A; Tsutamoto T; Sawaki M; Fujii M; Matsumoto T; Kinoshita M
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S140-3. PubMed ID: 11078360
[TBL] [Abstract][Full Text] [Related]
18. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T; Davenport AP; Edvinsson L
Br J Pharmacol; 1994 Jun; 112(2):477-86. PubMed ID: 8075866
[TBL] [Abstract][Full Text] [Related]
19. Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.
Tikkanen I; Tikkanen T; Cao Z; Allen TJ; Davis BJ; Lassila M; Casley D; Johnston CI; Burrell LM; Cooper ME
J Hypertens; 2002 Apr; 20(4):707-14. PubMed ID: 11910307
[TBL] [Abstract][Full Text] [Related]
20. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
Ebihara I; Nakamura T; Tomino Y; Koide H
Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
